Litcius/Paper detail

Body composition and weight changes after ivacaftor treatment in adults with cystic fibrosis carrying the G551 D cystic fibrosis transmembrane conductance regulator mutation: A double-blind, placebo-controlled, randomized, crossover study with open-label extension

Susannah J. King, Audrey Tierney, Deirdre Edgeworth, D. Keating, E. Williams, Tom Kotsimbos, Brenda Button, John Wilson

2021Nutrition47 citationsDOI

Topics & Concepts

IvacaftorCystic fibrosisBody mass indexCrossover studyPlaceboGastroenterologyInternal medicineMedicineCystic fibrosis transmembrane conductance regulatorEndocrinologyWeight gainAnimal scienceChemistryBody weightPathologyBiologyAlternative medicineCystic Fibrosis Research AdvancesAsthma and respiratory diseasesDelphi Technique in Research
Body composition and weight changes after ivacaftor treatment in adults with cystic fibrosis carrying the G551 D cystic fibrosis transmembrane conductance regulator mutation: A double-blind, placebo-controlled, randomized, crossover study with open-label extension | Litcius